1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMax Gray Fund For Treatment Of Mood Disorders is sponsored by Semel Institute for Neuroscience and Human Behavior at UCLA. Supports the expansion of mood disorders clinics, including the Child and Adolescent Mood Disorders Clinic, to provide diagnostic evaluations and treatments for youth with significant mood disorders.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Max Gray Fund For Treatment Of Mood Disorders – Semel Institute Help us celebrate 50 years of the Semel Institute. Learn more Max Gray Fund For Treatment Of Mood Disorders Development, Neuroscience Dlintilhac@mednet. ucla.
edu Max Gray was passionate about film, art music and life. In 2006, he graduated from Harvard-Westlake School, where he was captain of the Varsity lacrosse team. In 2010, he graduated from the Gallatin School at New York University and went on to work as an executive assistant at Creative Artists Agency and later as an associate at OddLot Entertainment, a Los Angeles-based motion picture production company.
In August 2013, at the age of 25, Max died by suicide. To honor Max’s memory and to reduce the toll of anxiety and depression, Laurie Davis Gordon established the Max Gray Fund for Treatment of Mood Disorders at the Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA in 2014. To date, more than $3 million has been raised through the generosity of friends and family of the Gray and Gordon families.
This initiative has enabled the expansion of the mood disorders clinic to recruit and train fifteen psychiatry and postdoctoral psychology fellows, increasing their capacity to diagnose and treat patients according to the most up-to date methods, and conduct innovative research in mood disorders.
The Adult Mood Disorders Clinic at the Semel Institute provides clinical evaluations and ongoing treatment for patients with depression and bipolar disorder. The Child and Adolescent Mood Disorders Clinic offers diagnostic evaluations, second opinion consultations, and short-term pharmacological and psychosocial treatments for youth with significant and impairing mood disorders, as well as resources for their families.
Philanthropy has been instrumental in enabling both clinics to increase new patient intake by approximately 30 percent. As a result of the Max Gray Fund, more patients and families are receiving appropriate and effective care. More young doctors are being trained in the most advanced methods of treating these patients.
More lives are being saved. UCLA is proud to announce the UCLA Max Gray Child and Adolescent Mood Disorders Program (Max Gray CHAMP) as a lasting tribute to Max. Please consider supporting the Max Gray Fund: Online: www.
giving. ucla. edu/MaxGrayFund Check: Make payable to The UCLA Foundation with “Max Gray Fund” in the memo line, mail to Daisy Lintilhac, The UCLA Foundation, PO Box 7145, Pasadena, CA 91109-7145 For more information, please contact: Development, Neuroscience Dlintilhac@mednet.
ucla. edu To discuss making a gift of $25K or more Senior Director of Development Madeline Jansen M. D.
M. P. H.
2025-26, Child and Adolescent Mood Disorders Clinic 2021-25, Child and Adolescent Mood Disorders Clinic 2023-25, Child and Adolescent Mood Disorders Clinic Jessica Burns, Psy. D. , M.
A. 2023-25, Child and Adolescent Mood Disorders Clinic 2022-25, Child and Adolescent Mood Disorders Clinic 2020-25, Child and Adolescent Mood Disorders Clinic Brittany Booth, M. D.
, M. P. H Jennifer M.
Gamarra, Ph. D. 2021-2022, Child and Adolescent Mood Disorders Clinic 2020-21, Child and Adolescent Mood Disorders Clinic 2020-21, Adult Mood Disorders Clinic DS Adnan Majid, M.
D. , Ph. D.
2019-20, Adult Mood Disorders Clinic 2019-20, Adult Mood Disorders Clinic 2018-19, Adult Mood Disorders Clinic Artha Gillis, M. D. , Ph.
D. 2018-19 and 2019-20, Child and Adolescent Mood Disorders Clinic 2017-18, Adult Mood Disorders Clinic 2017-18, Child and Adolescent Mood Disorders Clinic Elizabeth Horstmann, M. D.
2016-17, Child and Adolescent Mood Disorders Clinic Alaina Burns, M. D. , M.
P. H. 2016-17, Adult Mood Disorders Clinic 2018-19, 2019-20, and 2020-21 Child and Adolescent Mood Disorders Clinic 2015-16 Adult Mood Disorders Clinic Lisa O’Donnell, LMSW, Ph.
D. 2015-16, Child and Adolescent Mood Disorders Clinic Tips from the Max Gray Fellows CHAMP Newsletter Winter 2023 Annual Fellows Salon Videos Child & Adolescent Psychiatry Max Gray Child and Adolescent Mood Disorders Program (CHAMP)
According to the current listing, eligibility includes: Universities, Nonprofits, State/local governments. Confirm the full requirements in the official notice before applying.
Max Gray Fund For Treatment Of Mood Disorders is funded by Semel Institute for Neuroscience and Human Behavior at UCLA. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On August 26, 2026, NSF named the STC class of 2026: TEMPEST at Michigan State, GENIE at Northwestern, and a human-robot co-adaptation center at UT Austin. $90 million total, $6 million a year each. The 2023 class was four centers and $120 million. The award size is intact; the shelf space shrank 25 percent — and that is the number that should reshape how you plan a center proposal.
Read articleThe STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read articleThe Complement-ARIE program funds seven technology centers to develop human-based models that complement animal research. What it means for drug developers, academic researchers, and the regulatory pipeline.
Read article